Lithuania
1

Intellectual property

logo

Cobalt

Mehr Information
The IP team at Cobalt is significantly active in the field of pharmaceutical IP work and it receives a steady workflow in regulatory, IP transactions, trademark and design prosecution, and IP enforcement work. Intellectual property, information technologies and data protection remain core areas for the team, with the practice regularly advising global players in these markets. The team has been engaged by various clients to advise on the management of their trademark portfolios, with a strong track record of successful outcomes in trademark and patent-related disputes. The team is led by Žilvinas Kvietkus, who has a well-established practice in the areas of life sciences and pharmaceutical law, handling a range of related intellectual property and dispute resolution work in these sectors.
Legal 500 redaktioneller Kommentar
Profil
cobalt.legal

Referenzen

Unabhängig vom Legal 500-Forschungsteam zusammengestellt.

  • ‘Excellent knowledge in the industry, always well within reach and very client-orientated.’

  • ‘Žilvinas Kvietkus has shown excellent teamwork to reach the best possible result for us as a client providing a profound and clear picture in a complex matter.'

  • ‘Super high quality and one of the best for pharma patent litigation teams in the Baltics.'

  • ‘Deep technical understanding of complex patent disputes, very attentive to detail.'

  • ‘The Cobalt patent litigation team has an in-depth knowledge of patent law and practice before the Lithuanian courts.’

Kernmandanten

  • Berlin-Chemie AG
  • Bayer Intellectual Property GmbH
  • Novartis Group
  • Bristol-Myers Squibb Holdings Ireland Unlimited Company
  • Meril Life Sciences Pvt. Ltd
  • ÇOLAKOĞLU METALURJİ A.Ş.

Highlight-Mandate

  • Representing Bayer Intellectual Property GmbH in a complex patent invalidation case.
  • Representing Berlin-Chemie AG in a civil case against a parallel importer UAB Lex Ano regarding the parallel import of the medicinal products “Letrox” from Hungary to Lithuania, which were reboxed and renamed “L-Thyroxin Berlin-Chemie”.
  • Representing Bristol-Myers Squibb Holdings Ireland Unlimited Company in a patent invalidation case initiated by EGIS Gyogyszergyar Zrt.

Anwält*innen

Führende Partner*innen

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Führende Associates

Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.

Praxisleitung

Žilvinas Kvietkus